BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ohno M, Otsuka M, Kishikawa T, Yoshikawa T, Takata A, Koike K. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA. World J Gastroenterol 2015; 21(23): 7084-7088 [PMID: 26109795 DOI: 10.3748/wjg.v21.i23.7084]
URL: https://www.wjgnet.com/1007-9327/full/v21/i23/7084.htm
Number Citing Articles
1
Frank Buchholz, Joachim Hauber. Antiviral therapy of persistent viral infection using genome editingCurrent Opinion in Virology 2016; 20: 85 doi: 10.1016/j.coviro.2016.09.012
2
Lung-Yi Mak, Wai-Kay Seto, James Fung, Man-Fung Yuen. Novel developments of hepatitis B: treatment goals, agents and monitoring toolsExpert Review of Clinical Pharmacology 2019; 12(2): 109 doi: 10.1080/17512433.2019.1567327
3
Kazuma Sekiba, Motoyuki Otsuka, Motoko Ohno, Mari Yamagami, Takahiro Kishikawa, Tatsunori Suzuki, Rei Ishibashi, Takahiro Seimiya, Eri Tanaka, Kazuhiko Koike. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNAWorld Journal of Gastroenterology 2018; 24(21): 2261-2268 doi: 10.3748/wjg.v24.i21.2261
4
Thuy Thi Bich Phung, Son Van Chu, Son Thien Vu, Hanh Thi Pham, Hang Minh Nguyen, Hoan Dang Nguyen, Ngan Thi Le, Dung Van Nguyen, Phuong Thai Truong, Van Thi Tuong Vu, Anh Thi Van Nguyen. COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis BDiagnostics 2020; 10(7): 491 doi: 10.3390/diagnostics10070491
5
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C virusesWorld Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
6
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis BDrugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
7
Sajad Ahmad Bhat, Syed Naqui Kazim. HBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional CureACS Omega 2022; 7(28): 24066 doi: 10.1021/acsomega.2c02216
8
Ruiting Li, Qin Wang, Kaiqin She, Fang Lu, Yang Yang. CRISPR/Cas systems usher in a new era of disease treatment and diagnosisMolecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00095-y
9
Cheng Peng, Mengji Lu, Dongliang Yang. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBVVirologica Sinica 2015; 30(5): 317 doi: 10.1007/s12250-015-3660-x
10
Kunihiro Hasegawa, Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kazunori Yoh, Noriko Ishii, Yukihisa Yuri, Takashi Nishimura, Hiroko Iijima, Etsuro Hatano, Jiro Fujimoto, Shuhei Nishiguchi. Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis BHepatology Research 2019; 49(3): 271 doi: 10.1111/hepr.13280
11
Sema Alacam, Nuran Karabulut, Ayfer Yolcu, Mustafa Onel, Alp Atasoy, Sabahattin Kaymakoglu, Ali Agacfidan. Evaluation of drug resistance mutations in patients with chronic hepatitis BFolia Microbiologica 2019; 64(2): 237 doi: 10.1007/s12223-018-0650-z
12
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine. Critical Updates on Chronic Hepatitis B Virus Infection in 2021Cureus 2021;  doi: 10.7759/cureus.19152
13
Kazuto Tajiri, Yukihiro Shimizu. New horizon for radical cure of chronic hepatitis B virus infectionWorld Journal of Hepatology 2016; 8(21): 863-873 doi: 10.4254/wjh.v8.i21.863